 |
|
|
| |
STaR: Virologic Outcomes and Safety in ART-Naïve Adult Females for Single-Tablet Regimen Rilpivirine/Emtricitabine/Tenofovir DF Compared to Efavirenz/Emtricitabine/Tenofovir DF at Week 48
|
| |
| |
Reported by Jules Levin
53rd Interscience Conference on
Antimicrobial Agents and Chemotherapy (ICAAC)September 10-13, 2013
Denver, CO, USA
C Brinson1, S Segal-Maurer2, I Brar3, C Creticos4, C McDonald5, B Wade6, R Ebrahimi7, D Porter7, S De-Oertel7, T Fralich7, J DeMorin7, K Khorana7
1Central Texas Clinical Research, Austin, TX, USA; 2New York Hospital Queens, Flushing, NY, USA; 3Henry Ford Hospital, Detroit, MI, USA; 4NorthShore University Health System, Chicago, IL, USA; 5Tarrant County Infectious Disease, Fort Worth, TX, USA; 6Center for Prevention/Treatment, Pensacola, FL, USA; 7Gilead Sciences, Foster City, CA, USA
|
| |
|
|
|
|
|
